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Abstract 
Aims:   To compare functional characteristics of thoraco-abdominal arteries and veins 
in proteinuric and non-proteinuric hypertension in pregnancy. 
Material and methods: This retrospective study includes singleton pregnancies of 
women during uncomplicated third trimester (UP), with non-proteinuric gestational 
hypertension (GH), with early-onset preeclampsia (PE) diagnosed < 34 weeks (EPE) or with 
late-onset PE ≥ 34 weeks (LPE). Demographic maternal and neonatal data were recorded 
together with maternal serum and urine analytes. All women had standardised automated 
blood pressure measurement, together with non-invasive Impedance Cardiography (ICG) for 
measurement of cardiac output (CO), aorta flow velocity (VI) and acceleration (ACI).  A 
standardised combined Doppler – ECG assessment of maternal venous hemodynamics was 
done for measurement of Renal Interlobar Vein Impedance Index (RIVI), Hepatic Vein 
Impedance Index (HVI) and venous pulse transit time (VPTT) in liver and kidneys. Finally, 
resistivity index (RI), pulsatility index (PI) and arterial pulse transit time (APTT) were 
measured at the uterine arcuate arteries. SPSS software Version 20.0 was used for statistical 
comparison at nominal level α = 0.05, using a non-parametric Mann-Whitney U-tests for 
intergroup comparison of continuous data and Fisher’s exact tests for categorical data. 
Significant linear dependence between clinical, laboratory, ICG and Doppler-ECG variables 
was identified using Pearson’s correlation coefficient (PCC) at nominal level α=0.05 (two-
tailed), and coefficient of determination R2 and corresponding p-value were calculated.  
Results:  A total of 150 pregnancies were evaluated: 22 UP, 41 GH, 31 EPE and 56 
LPE. Aorta VI and ACI were lower in GH, EPE and LPE than in UP. Both EPE and LPE 
differed from GH by shorter APTT at uterine arcuate arteries and higher RIVI and HVI. 
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Hemodynamic abnormalities were most pronounced in EPE, where uterine arcuate artery RI 
was higher and VPTT in kidneys and liver were shorter than in LPE. There was a relevant 
coefficient of determination  between degree of proteinuria and RIVI for left (R² = 0.145) and 
right kidney (R² = 0.120) in LPE, which was not true for EPE.   
Conclusion:  There is a gradual aggravation of arterial and venous hemodynamic 
abnormalities from GH to LPE and finally EPE. Venous hemodynamic abnormalities are 
only present in preeclampsia, with a linear correlation between proteinuria and RIVI in LPE. 
The role of the maternal venous compartment in the pathophysiology and etiology of PE-
related symptoms may be much more important than considered today.  
 
 
Introduction  
Normal circulation of the blood requires the coordinated activity of several systems in the 
cardiovascular circuit: the heart, the arterial compartment, the microcirculation, the venous 
compartment and the blood. Cardiovascular profiling is defined as the evaluation of the 
functionality of these systems for categorisation of the cardiovascular system into functional 
subtypes 1,2. For this, invasive and non-invasive methods can be used 3,4. Cardiovascular 
profiling in pregnant women can be performed non-invasively using standardized combined 
Doppler-electrocardiography (D-ECG) assessment 5 and Impedance Cardiography (ICG) 6,7.  
Cardiovascular dysfunction has been reported as less severe in gestational hypertension than 
in preeclampsia 8-10 and pharmacologic response was found to differ between both entities 8. 
Similarly, cardiac, arterial and venous hemodynamic dysfunction was found to present less 
severe in late-onset than in early-onset preeclampsia 11-13, and maternal serum concentrations 
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of angiogenic factor differed between both entities 14. Micro-circulatory changes were also 
reported to differ between preeclampsia and HELLP-syndrome 15.  
In this paper, we report our observations on the non-invasive maternal cardiovascular profile 
with D-ECG and ICG in women with different clinical types of hypertension in pregnancy, 
relative to the findings in uncomplicated pregnancies (UP): gestational hypertension (GH), 
early-onset preeclampsia (EPE) and late-onset preeclampsia (LPE).   
Materials and methods 
Approval of the ethical committee was obtained before study onset (MEC ZOL reference: 
08/049, 09/050 and 10/065). 
Women, admitted between 1/10/2009 and 31/12/2013 to the Fetal Maternal Medicine Unit of 
Ziekenhuis Oost Limburg Genk Belgium for hypertension in pregnancy were included. 
Exclusions were women with multiple gestation, essential hypertension with or without 
superimposed preeclampsia, renal disease with or without proteinuria, history of organ 
transplantation, women with concomitant diseases as diabetes, thyroid dysfunction, auto-
immune disease, cholestasis or liver disease, women with HELLP syndrome, women with 
thrombocytopenia or with non-hypertensive proteinuria and IUGR without associated 
maternal symptoms. Included were only those women without known diseases and new onset 
hypertension > 20 weeks (Fig 1). In addition to this, a group of women with normal maternal 
and neonatal outcome at birth, who were admitted to the antenatal unit for presumed 
hypertension in the third trimester of pregnancy, were used as a control group. PE was 
defined as new onset gestational hypertension (≥ 140/90mmHg on at least 2 occasions at least 
6 hours apart) with de novo proteinuria (≥ 300mg/24hours) without thrombocytopenia or 
liver dysfunction, according to the criteria of the National High Blood Pressure Education 
Program Working Group 16,17. New onset hypertension > 20 weeks with proteinuria < 300 
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mg/24h is defined as gestational hypertension (GH). PE < 34 weeks is defined as early onset 
preeclampsia (EPE), whereas PE ≥ 34 weeks is defined as late onset preeclampsia (LPE). As 
such, there were 4 categories eligible for retrospective analysis: uncomplicated pregnancies 
(UP), gestational hypertension without proteinuria (GH), early onset preeclampsia (EP) and 
late onset preeclampsia (LP). 
For each woman, data on demographics and perinatal outcome were recorded, together with 
results from serum and urine biochemistry, ICG-measurements and maternal Doppler-ECG 
parameters. Maternal demographic data include age (years), body mass index (BMI) at first 
visit as recorded from the records, gestational age at assessment (weeks), parity and use of 
antihypertensive medication. Data on perinatal outcome comprise gestational age at delivery 
(weeks), birth weight (BW in g) and customized birth weight percentile (BW% in %). Serum 
parameters include thrombocytes (1000/µL), creatinine (µmol/L), aspartate aminotransferase 
(ASAT in U/L), alanine aminotransferase (ALAT in U/L), and uric acid (µmol/L). 
Parameters evaluated in 24 hour urine collections at the time of diagnosis of PE were 
creatinine clearance (mL/min), and proteinuria over 24 hours (mg).  
At the same time point, all women had an Impedance Cardiography (ICG-) assessment 
together with a combined Doppler-ECG (D-ECG-) evaluation at different sites of the 
circulation, as illustrated in Figure 2.  None of the subjects were in labour at the time of the 
investigations. 
ICG- examinations were performed in standing position using the Non-Invasive Continuous 
Cardiac Output Monitor (NICCOMO©, Software version 2.0, Medis Medizinische 
Messtechnik GmbH, Ilmenau Germany) according to the reported methodology and protocol 
with known repeatability 6. This impedance technique is a non-invasive method of evaluating 
haemodynamic parameters, based on thoracic resistance changes of a high frequent, low 
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powered electrical current, measured during each heart cycle using a set of 4 skin-electrodes 
18,19. Blood pressures were measured standardised using the automated device of the 
NICCOMO-monitor. Pressure parameters were systolic blood pressure (SBP), diastolic blood 
pressure (DBP), pulse pressure (PP = SBP – DBP) and mean blood pressure (MBP = DBP + 
PP/3), all expressed in mmHg. ICG-parameters were left ventricular output parameters, aortic 
flow parameters, and thoracic fluid content (TFC in 1/kOhm) 6,18. Left ventricular output 
parameters were stroke volume (SV) in mL, heart rate (HR) in beats/min and cardiac output 
in mL/min (CO = HR x SV). Aortic flow parameters were velocity index (VI in 1/1000/s) 
which is equivalent to the amplitude of the systolic wave and acceleration index (ACI in 
1/100/s²) which stands for the maximum acceleration of blood flow in the aorta 6,18. Thoracic 
fluid content is measured directly from the electrical conductivity of the chest and reflects the 
total of intracellular, interstitial and circulation fluid volumes in the thorax 6,18.  
All Doppler-ECG examinations were done by 5 sonographers (WG, TM, AS, KT and SV) 
according to the protocol reported elsewhere 20,21, with known intra - and interobserver 
correlation 22. All women had ECG-D investigations in supine position at the level of hepatic 
veins (HV), renal interlobar veins (RIV) of both kidneys, and left and right arcuate uterine 
arteries as reported 20. Uterine arcuate arteries were preferred over uterine arteries for their 
intra-parenchymatous localization, comparable with the localization of hepatic and renal 
interlobar veins 23, and were performed within a maximum of 2 cm distance from the 
bifurcation at the uterine artery. Arterial pulsatility and resistivity index were measured, 
defined as [(maximum velocity (MxV) – minimum velocity (MnV)]/mean velocity  and 
[MxV – MnV]/MxV respectively. Doppler parameters measured at the level of HV and RIV 
were MxV and MnV. From this, Hepatic Vein velocity index (HVI) and Renal Interlobar 
Vein Impedance Index (RIVI) were calculated as [(MxV-MnV)/MxV] 20,24. Pulse transit 
times were measured as the time interval between corresponding characteristics of the cardiac 
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cycle of the ECG-signal and Doppler wave. Arterial pulse transit time (APTT) was defined as 
the time interval (ms) between the maternal ECG Q-wave and start of Doppler systole, 
corrected for the duration of the corresponding cardiac cycle 23. Venous pulse transit times 
(VPTT) were defined as the time interval (ms) between the maternal ECG P-wave and 
corresponding Doppler A-wave, again corrected for the duration of the corresponding cardiac 
cycle 25.  
Data are presented as medians with first and third quartiles, or as percentages. SPSS software 
Version 20.0 was used for statistical comparison at nominal level α = 0.05, using a non-
parametric Mann-Whitney U-tests for intergroup comparison of continuous data and Fisher’s 
exact tests for categorical data. Significant linear dependence between clinical, laboratory, 
ICG and ECG-Doppler variables was identified using Pearson’s correlation coefficient (PCC) 
at nominal level α=0.05 (two-tailed), and goodness-of-fit of the resulting linear regression 
model with heteroskedastic variance was reported by coefficient of determination R2 and 
corresponding p-value (SAS software V9.2).  
Results 
A total of 150 women were included: 22 had UP, 41 had GH, 31 had EPE and 56 had LPE. 
Inclusions and exclusions in this study from the total cohort of women, admitted to the 
hospital for hypertension in pregnancy during the study period, are presented in Figure 1.   
Demographic data are presented in Table 1, together with results from maternal serum and 
urine laboratory tests.  
Table 2 shows the blood pressure values and ICG measurements of cardiac output, aortic 
flow velocities and thoracic fluid content. As is shown, HR, SV or CO were not different 
between groups. For GH, LPE and EPE, aortic flow VI and ACI were lower than in UP.  
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Table 3 presents the D-ECG results as measured at the level of hepatic veins, renal interlobar 
veins and uterine arcuate arteries. Only in preeclampsia, venous impedance index and arterial 
pulse transit times were different from UP. Arterial resistivity and pulsatility index and 
venous pulse transit times were different from UP only in EPE. Interestingly in late-onset 
preeclampsia, left and right kidney RIVI correlated with degree of proteinuria:  PCC for the 
left kidney was 0.381 (p=0.004, R² = 0.145) and PCC for the right kidney was 0.347 
(p=0.010, R² = 0.120). These correlations correspond to regression-based predictions as 
proteinuria = 9E2+5.29E3 x Left RIVI and Proteinuria = 4.58E2+4.41E3 x Right RIVI. No 
correlation was found between proteinuria and RIVI in early-onset preeclampsia: PCC for the 
left kidney was 0.073 (p=0.696, R² = 0.005) and PCC for the right kidney was 0.234 
(p=0.214, R² = 0.055). 
The most important findings of Tables 2 and 3 are summarized in Table 4. As compared to 
UP, hemodynamic dysfunction aggravates from GH to LPE and finally EPE.  
Discussion 
The data presented in this report support the view that (1) central arterial hemodynamic 
dysfunction is present in both gestational hypertension and preeclampsia, and (2) 
preeclampsia presents with signs of venous hemodynamic dysfunction, which is not true for 
gestation induced hypertension.  
Our study is original because it evaluates aspects of hemodynamics at different sites of the 
maternal circulation: central and peripheral arterial hemodynamics together with venous 
hemodynamics. The strengths of our study are that every woman is examined according to a 
standard protocol using non-invasive assessment techniques with known inter- and intra-
observer correlation 6,18,22. Next to this, the patients included in each group strictly comply 
with all reported criteria for each disorder, and are free of interfering maternal or gestational 
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diseases known at time of inclusion. The lack of a physiologic explanation for the true nature 
of the venous impedance index as a venous Doppler flow characteristic, as well as the lack of 
associative data on experimental measurements of central venous pressure and venous 
vascular tone in preeclampsia, are a limitation to our study. Next to this, our observational 
study is retrospective in nature, which does not allow drawing conclusions on cause and 
effect relationships or on the individual role of heart, arteries and veins in the development or 
the clinical presentation of PE. For this, a prospective clinical study in a large group of 
women and experimental data are needed. 
Our data are consistent with the observations from others, reporting a gradation in 
hemodynamic dysfunction and severity of clinical presentation between subtypes of 
gestational hypertensive diseases, with EPE as the most severe subtype 8-11. Next to this, our 
observations are also in line with the ICG-measurements in pregnant hypertensive women as 
reported by Parrish et al 26, illustrating central arterial hemodynamic dysfunction and 
increased thoracic fluid content in the most severe subtypes of PE.  
Next to this, our data in Table 3 illustrate that maternal venous hemodynamic dysfunction is a 
feature of both early- and late-onset preeclampsia, but not GH. Venous hemodynamic 
dysfunction in PE was reported for the first time by Bateman et al 27. In former publications, 
we have reported that RIVI is higher in EPE than in LPE 13 and that HVI is also increased in 
PE, as compared to UP 21.  The higher values of RIVI in EPE than in LPE were linked to the 
presence of the so-called Doppler wave venous pre-acceleration nadir (VPAN) 5,13. VPAN 
results from the retrograde intravenous rebound of right atrial contraction, which in PE 
presents up to the level of the kidneys resulting in a more pronounced deceleration of blood 
flow and higher RIVI-values. It is unclear whether this rebound in PE relates to increased 
cardiac diastolic dysfunction 2 or to reduced venous distensibility 28. Pulse transit time is 
considered a measure for vascular stiffness: in conditions of increased vascular tone or 
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stiffness, the propulsion wave is transported faster through the circulation than in conditions 
of low vascular tone, and this is responsible for a shorter time interval between ECG and 
pulse or Doppler wave 29-31. During PE, shorter pulse transit times have been measured at 
both the arterial 32 and venous sites of the circulation 23. It is likely that increased venous tone 
in PE is associated with a faster and more distant rebound of atrial contraction throughout the 
venous circulation, up to the level of the kidneys. As such, increased RIVI, with or without 
VPAN, can be considered a reflection of pulsatile counteraction of forward venous flow from 
the kidneys, which intermittently counteracts renal outflow during each atrial contraction 33. 
Our observations of increased Doppler Impedance Index and shortened venous pulse transit 
times in intrarenal veins are compatible with a state of increased intravenous or intravenular 
hydrostatic pressure. Therefore, we propose renal venous congestion as an additional 
explanation for some of the clinical manifestations of PE. A decrease of venous outflow from 
the kidneys will result in a decrease of glomerular plasma flow and glomerular filtration rate. 
In order to maintain the glomerular filtration rate, local renin angiotensin aldosteron system 
(RAAS) will be activated by stimulation of the juxtaglomerular apparatus 34. This intrarenal 
production of angiotensin II (Ang II) will result in proteinuria 35 and increased salt sensitivity  
with subsequent edema and hypertension 36. In PE circulating RAAS remains suppressed or 
unchanged 37. Upregulation of Ang II Receptor-1 and increase of Ang II Receptor-1 Auto-
Antibody in PE might further enhance the Ang II sensitivity 38. Raised Ang II levels can 
cause proteinuria by several mechanisms: increased glomerular pressure, endothelial cell 
dysfunction, contraction of the podocytes and reduced expression of nephrin 39. 
Experimentally induced increase of intravenous pressure in the renal veins 40 or 
subobstruction to venous drainage from the kidneys has been shown to result in overt 
proteinuria, partially reversible by Ang II antagonism 35. Proteinuria due to renal congestion 
has also been described in the nutcracker syndrome where the left renal vein is narrowed in 
This article is protected by copyright. All rights reserved 
the angle between the aorta abdominalis and the arteria mesenterica superior, leading to 
orthostatic proteinuria mainly in young adults. The improvement of this type of proteinuria 
by ACE inhibition demonstrates an etiologic role for Ang II 41. The correlation we found 
between RIVI and degree of proteinuria in LPE suggests a possible underrecognised role for 
venous hemodynamics in the pathophysiology of PE, and invites for more research into the 
pathophysiology of PE-related proteinuria.  
 
Conclusion 
The combination of our observations allow describing the cardiovascular profile for different 
types of hypertensive disease in pregnancy : (1) gestational hypertension combines increased 
blood pressures with central hemodynamic dysfunction, and (2) preeclampsia presents as 
gestational hypertension with venous hemodynamic dysfunction.  
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Table 1: Maternal demographics, neonatal outcome and laboratory results. 
UP GH LPE EPE 
n=22 n=41 n=56 n=31 
 
Maternal age (y) 29.00 (24.75;31.25) 30.00 (26.00;32.50) 28.00 (25.25;30.75) 29.00 (26.00;30.00) 
Start BMI 25.06 (20.11;28.48) 25.90 (22.72;30.02) 25.08 (23.22;28.64) 24.48 (21.80;28.81) 
Nulliparity n (%) 11 (50%) 28 (68.3%) 47 (83.9%) 22 (71.0%) 
$ Q * ° 
Medication n (%) 0 (0%) 3 (7.3%) 5 (8.93%) 3 (9.68%) 
GA examination (w) 36.79 (34.11;39.46) 38.00 (36.65;39.21) 37.50 (36.00;38.39) 31.28 (27.28;32.72) 
Q Q Q $°* 
GA birth (w) 39.72 (37.14;40.43) 39.14 (37.93;39.93) 37.65 (36.32;38.72) 31.72 (27.86;33.14) 
$Q $Q °Q* $°* 
Birth weight (g) 3465 (2923.75;3695.0) 3080.0 (2710.0;3552.5) 2850 (2465;3260) 1425.0 (992.0;1730.0) 
$Q Q Q* $°* 
Birth weight %  50.00 (21.25;75.00) 25.00 (10.00;62.50) 25.00 (10.00-68.75) 25.00 (10.00,25.00) 
Q * 
 
Hemoglobin (g%) 12.35 (11.53;12.80) 12.10 (11.75;12.90) 11.95 (10.90;12.88) 12.10 (11.40;13.10) 
Thromb (x1000/mm³) 207.50 (168.25;235.50) 208.00 (166.50;241.00) 182 (152;229) 176.00 (150.0;209) 
ASAT (U/L) 17.00 (15.00;19.25) 18.00 (15.00;22.50) 18.00 (15.00;24.00) 19.00 (16.00;25.50) 
ALAT (U/L) 11.00 (9.00;12.25) 12.00 (9.00;14.50) 12.00 (9.00;17.25) 16.00 (10.00;23.00) 
Q * 
Uric Acid (µmol/L) 4.65 (3.88;5.70) 5.48 (4.67;6.49) 5.95 (5.03;6.98) 6.60 (5.40;7.70) 
$°Q $Q* *° °* 
ProtU24h (mg) 144.50 (112.75;174.50) 164.0 (111.5;204.0) 786 (434;1639) 2543 (838.0;7322.0) 
$Q $Q Q°* $°* 
Creat Clear (ml/min) 131.07 (106.14;154.04) 125.73 (104.16;157.73) 121.94 (94.96;151.62) 116.72 (93.27;141.85) 
 
* Significantly different from Uncomplicated Pregnancy (UP)   
° Significantly different from Gestational Hypertension (GH)    
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$ Significantly different from Late-onset Preeclampsia (LPE) 
Q  Significantly different from Early-onset Preeclampsia (EPE) 
BMI : Body Mass Index at first antenatal visit 
GA: gestational age (w) 
Thromb: thrombocytes (x 1000/mm³) 
ASAT: Aspartate Aminotransferase (U/L) 
ALAT: Alanine Aminotransferase (U/L) 
ProtU24h: 24 hour proteinuria (mg) 
CreatClear: creatinine clearance (mL/min) 
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Table 2: Blood pressure values and impedance cardiography measurements 
UP GH LPE EPE 
n=22 n=41 n=56 n=31 
 
SBP (mm Hg) 137.50 (122.00;147.00) 149.0 (141.50;159.50) 149.0 (135.25;163.75) 153.00 (141.00;166.00) 
$°Q * * * 
DBP (mm Hg) 87.50 (82.50;99.75) 98.0 (94.50;104.0) 98.00 (93.0;103.0) 102.0 (96.0;108.0) 
$°Q * * * 
MAP (mm Hg) 99.50 (93.75;111.50) 112.0(107.0;118.0) 110.0 (103.0;117.75) 113.0(108.0;122.0) 
$°Q * * * 
 
Heart rate (bpm) 97.0 (84.50;106.50) 94.0 (89.0;105.5) 90.0 (82.0;102.5) 94.0 (86.0;105.0) 
$ ° 
Stroke volume (ml) 77.50 (67.00;93.25) 82.0(64.0;94.5) 85.00 (61.00;99.00) 75.00 (67.00;90.0) 
Card output (L/min) 7.30 (6.55;8.10) 7.50 (6.25;8.80) 7.70 (6.10;9.08) 7.10 (6.20;8.10) 
VI (1/1000/s) 59.50 (50.75;65.25) 46.00 (39.50,58.00) 45.00 (38.25;55.75) 45.00 (35.00;56.00) 
$°Q * * * 
ACI (1/100/s²) 111.50 (86.5;147.0) 76.00 (59.00;102.50) 84.00 (6.50;98.25) 80.00 (58.00;108.75) 
$°Q * * * 
TFC (1/kOhm) 27.05 (24.85;29.60) 24.75 (24.75;29.45) 30.60 (27.85;34.85) 34.10 (29.20;39.00) 
$Q $Q Q°* $°* 
 
* Significantly different from Uncomplicated Pregnancy (UP) 
° Significantly different from Gestational Hypertension (GH) 
$ Significantly different from Late-onset Preeclampsia (LPE) 
Q  Significantly different from Early-onset Preeclampsia (EPE) 
SBP: Systolic blood pressure  (mm Hg) 
DBP: Diastolic blood pressure (mm Hg) 
MAP : Mean arterial pressure (mm Hg) 
Card Output: Cardiac output (L/min)     
VI : Aorta flow velocity index (1/1000/s) 
ACI : Aorta flow acceleration index (1/100/s²) 
TFC: thoracic Fluid Content (1/kOhm) 
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Table 3: Doppler-ECG measurements 
 
UP GH LPE EPE 
n=22 n=41 n=56 n=31 
 
LK RIVI 0.330 (0.295;0.420) 0.360 (0.32 ;0.428) 0.40 (0.34;0.45) 0.427 (0.37 ;0.510) 
$Q Q * °* 
RK RIVI 0.308 (0.27;0.35) 0.33 (0.282;0.389) 0.38 (0.33;0.44) 0.439 (0.367;0.544)
$Q $Q Q°* $°* 
HVI  0.220 (0.146;0.430) 0.270 (0.165;0.784) 0.52 (0.20;1.10) 0.920 (0.427;1.573)
$Q Q Q* $°* 
LK VPTT (sec) 0.437 (0.325;0.528) 0.410 (0.345;0.467) 0.37 (0.33;0.44) 0.327 (0.270;0.393)
Q Q Q $°* 
RK VPTT (sec) 0.40 (0.340;0.475) 0.40 (0.355;0.477) 0.38 (0.32;0.42) 0.335 (0.289;0.404)
Q $Q ° °* 
L VPTT (sec) 0.320 (0.265;0.395) 0.300 (0.227;0.377) 0.300 (0.205;0.410) 0.247 (0.170;0.343)
Q * 
 
L Aut  RI 0.520 (0.415;0.607) 0.550 (0.440;0.707) 0.549 (0.468;0.680) 0.707 (0.587;0.772)
Q Q Q $°* 
L Aut PI 0.710 (0.530;0.865) 0.750 (0.570;1.097) 0.755 (0.618;1.028) 1.095 (0.833;1.261)
Q Q Q $°* 
R Aut RI 0.457 (0.409;0.647) 0.460 (0.390;0.647) 0.515 (0.430;0.618) 0.717 (0.560;0.770)
Q Q Q $°* 
R Aut PI 0.570 (0.515;0.947) 0.610 (0.490;0.953) 0.702 (0.553;0.890) 1.112 (0.780;1.248)
Q Q Q $°* 
L Aut APTT (sec) 0.320 (0.267;0.375) 0.287 (0.252;0.340) 0.274 (0.231;0.310) 0.227 (0.218;0.288)
$Q $Q Q°* $°* 
R Aut APTT (sec) 0.340 (0.285;0.405) 0.303 (0.253;0.340) 0.272 (0.233;0.308) 0.235 (0.209;0.290)
$Q $Q Q°* $°* 
 
* Significantly different from Uncomplicated Pregnancy (UP) 
° Significantly different from Gestational Hypertension (GH) 
$ Significantly different from Late-onset Preeclampsia (LPE) 
Q  Significantly different from Early-onset Preeclampsia (EPE) 
LK RIVI : Left kidney, renal interlobar vein impedance index 
RK RIVI: Right kidney, renal interlobar vein impedance index  
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HVI: Hepatic vein impedance index 
LK VPTT: Left kidney, venous pule transit time (sec) 
RK VPTT : Right kidney, venous pule transit time (sec) 
L VPTT: Liver venous pule transit time (sec) 
L Aut RI: Left Uterine Arcuate Artery Resistivity index 
L Aut PI : Left Uterine Arcuate Artery Pulsatility index 
R Aut RI: Right Uterine Arcuate Artery Resistivity index  
R Aut PI: Right Uterine Arcuate Artery Pulsatility index  
L Aut APTT: Left Uterine Arcuate Artery Pulse transit time (sec) 
R Aut APTT: Right Uterine Arcuate Artery Pulse transit time (sec)  
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Table 4: Summary of most important findings of Tables 2 & 3. Arrows indicate significant 
differences relative to uncomplicated pregnancy.  
Blood pressures 
    GH LPE EPE
  SBP ↑ ↑ ↑
  DBP ↑ ↑ ↑
  MAP ↑ ↑ ↑
Arterial hemodynamics 
    GH LPE EPE
Aorta VI  ↓ ↓ ↓
ACI   ↓ ↓ ↓
Ut Arc Art Rt APTT   ↓ ↓
Lt APTT   ↓ ↓
R RI    ↑
L RI    ↑
Venous hemodynamics 
    GH LPE EPE
Rt kidney Rt RIVI   ↑ ↑
Rt VPTT    ↓
Lt kidney Lt RIVI      ↑ ↑
Lt VPTT    ↓
Liver  Hep VI   ↑ ↑
Hep VPTT    ↓
 
     SBP :  Systolic blood pressure 
GH : Gestational hypertension  DBP : Diastolic blood pressure 
LPE : Late onset preeclampsia  MAP : Mean arterial pressure 
EPE : Early onset preeclampsia  VI : Aorta flow velocity index 
ACI : Aorta flow acceleration index  Ut Arc Art : Uterine Arcuate Artery 
Rt : Right    Lt : Left 
APTT : Arterial pulse transit time  RI : Right resistivity index    
RIVI : Renal Interlobar vein impedance index VPTT : Venous pulse transit time 
Hep VI : Hepatic vein impedance index Hep VPTT : Hepatic vein pulse transit time 
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Figure captions 
Figure 1 
Flow chart of inclusions and exclusions in this study from the total number of women, 
admitted for hypertension in pregnancy to the Fetal Maternal Medicine Unit of Ziekenhuis 
Oost Limburg Genk Belgium during the study period. EH: essential hypertension, PE : 
preeclampsia, IUGR: Intra-uterine growth restriction, HELLP : Hemolysis Elevated Liver 
enzymes Low Platelets, Atypical PE: non-hypertensive proteinuria and/or elevated liver 
enzymes and/or low platelets. 
Figure 2 
Schematic presentation of the intra-abdominal locations where combined ECG-Doppler 
assessment were performed in study subjects: Hepatic Veins, Renal Interlobar Veins and 
Uterine Arcuate Arteries. Next to this, blood flow velocity characteristics in the thoracic aorta 
were assessed using Impedance Cardiography. (Figure adapted from  
http://www.cancer.gov/images/cdr/live/CDR649519-750.jpg). 
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Figure 1 
Atypical PE or HELLP 
n = 20 
HELLP 
n = 15 
Inclusions Exclusions 
Total :
n = 295 
Normal pregnancy  
excl IUGR 
n = 22 
Late onset preeclampsia 
incl IUGR 
n = 56 
Early onset preeclampsia 
incl IUGR 
n = 31 
Gestational hypertension 
incl IUGR 
n = 41 
IUGR 
n = 19 
Twins 
n = 29 
Maternal disease,  
Incl EH 
n = 59 
EH, superimposed PE 
n = 3 
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Figure 2 
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